Stay updated with breaking news from Ashesh Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of...
Company has a strong track record of offering end-to-end Biologics CDMO Services, developing complex biologics, inc development & licensing of biosimilars.
Paras Biopharmaceuticals is pleased to announce that the company has been identified as one of the Fastest Growing Companies in the Nordic Biotechnology...
Paras Biopharmaceuticals Finland Oy is seeking appropriate interest on a Reverse Merger to release its potential.
It is pleased to announce that from Q3-2022, company will be in a position to offer an expanded biologics CDMO capacity to European, USA & Canadian groups.